It's about understanding the hidden work your body performs during transformation and ensuring it has the tools to do that work efficiently
Barbalace MC, Talotta R, Rapisarda F, DAmico V, Lagan M, Malaguti M et al (2025) Unlocking the Power of the Mediterranean Diet: Two in One-Dual Benefits for Rheumatic and Thyroid Autoimmune Diseases
Seeking Medical Guidance Individualized Approach: Medical consultation ensures that your treatment is tailored to your needs, considering factors such as health conditions, medication interactions, and individual responses
Each pathway contributes a separate pharmacological signal: GLP-1 receptor agonism slows gastric emptying and reduces appetite signalling in the hypothalamus GIP receptor agonism enhances glucose-dependent insulin secretion and is associated in the literature with effects on lipid handling Glucagon receptor agonism increases energy expenditure and hepatic glucose output, the opposite direction to a glucagon antagonist, and is absent from every dual agonist currently on the UK market How retatrutide compares to dual agonists Tirzepatide (Mounjaro) is a GIP + GLP-1 dual agonist authorised by the MHRA for type 2 diabetes in 2023
.png)
